Amperos Health | $4,200,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
fabriq | $25,000,000 | (Jun 5, 2025)
Certified by Founder
Lodge
Therini Bio, Inc.
start up
United States
- South San Francisco, CA
- 27/04/2023
- Series A
- $36,000,000
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.
- Industry Biotechnology Research
- Website https://www.therinibio.com/
- LinkedIn https://www.linkedin.com/company/therinibio/
Obvio | $22,000,000 | (Jun 5, 2025)
Portless | $18,000,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)
Compyl | $12,000,000 | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Clara(US) | $3,100,000 | (Jun 4, 2025)
myLaurel® | $12,000,000 | (Jun 4, 2025)